Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

- Patients with otalgy or not, with acute external otitis ;

- Patients with at least two symptoms of otalgy (pain, discharge, tinnitus, ear fullness, subjective hearing loss temporary dizziness or vertigo) with the Visual Analogic Scale score between 4 and 8 (mild to moderate);

- The patient must present otalgia in one ear;

- Children above 6 years of age;

- Adults over 18 years of age;

- Patients who consent to participate in the study;

- Patients who are female and are of childbearing age should use reliable method of contraception and have negative pregnancy test.

- Patients with sensitivity to any component of the formula;

- Patients pregnant or lactating;

- Non visualization of the tympanic membrane of obstruction by cerumen;

- Patients with evidence of any wound or scratch on the ear (ulcerative lesion);

- Patients who are making use of any other medication that might interfere with the evaluation of effectiveness of study (such as antibiotics, antiinflammatory, solutions ear);

- Patients who have severe classification in the Visual Analogic Scale score 9 or 10 in any of the symptoms listed in the questionnaire;

- Patients with otalgy not otological origin;

- Patients with otitis, except acute external otitis ;

- Patients who have epiglottitis;

- The patient with infection;

- Patients who can not follow the procedures clarified in this protocol.